Truvada case shows civil society’s success with pre-grant opposition
The example of Gilead antiretroviral Truvada in Argentina and Brazil shows how civil society efforts to use patent opposition to...
Read more about Truvada case shows civil society’s success with pre-grant opposition
Thailand: Evergreened patents cause unwarranted high drug prices
Transnational drug manufacturers’ tactics of obtaining unmerited patent applications have unnecessarily raised healthcare costs and impeded the growth of domestic...
Read more about Thailand: Evergreened patents cause unwarranted high drug prices
Civil society key in TRIPS flexibility implementation
Civil society plays an instrumental role in actively defending access to affordable to medicines, making use of TRIPS flexibilities, and...
Read more about Civil society key in TRIPS flexibility implementation
Launched: I-MAK’s Special Edition Roadmap on Tenofovir Alafenamide Fumarate (TAF)
A critical analysis of TAF, as part of a Roadmap series, aims to help the international community assess the best...
Read more about Launched: I-MAK’s Special Edition Roadmap on Tenofovir Alafenamide Fumarate (TAF)
Gilead’s patent application on sofosbuvir rejected in Brazil
Rejected! That was the decision issued by Brazil’s National Institute of Industrial Property (INPI) over one of Gilead’s patent applications...
Read more about Gilead’s patent application on sofosbuvir rejected in Brazil
Ukraine eyes patent law reform after civil society push on medicines access
Ukrainian lawmakers are poised to approve sweeping patent reform legislation, driven in large part by a push by patients’ groups...
Read more about Ukraine eyes patent law reform after civil society push on medicines access
ADVOCATES PUBLISH COMMENTARY ON EXPANDING TREATMENT ACCESS FOR VIRAL HEPATITIS C
On 2 April 2018, an in-depth commentary on practical actions that can help increase access to HCV direct-action antivirals (DAAs)...
Read more about ADVOCATES PUBLISH COMMENTARY ON EXPANDING TREATMENT ACCESS FOR VIRAL HEPATITIS C
Botswana: Creating (radio) waves to show how intellectual property affects us all
BONELA is raising national awareness as to why intellectual property (IP) and access to medicines are relevant for everyone –...
Read more about Botswana: Creating (radio) waves to show how intellectual property affects us all
8 videos that explain the tension between HIV activists and Big Pharma
From Hollywood blockbusters, to investigative documentaries, to our own short, satirical animation, here are eight videos that show how the...
Read more about 8 videos that explain the tension between HIV activists and Big Pharma
Patent on Hep C drug rejected in Ukraine: Price of sofosbuvir will significantly reduce
The Ministry of Economic Development and Trade of Ukraine (MEDT) refused to grant the pharmaceutical company Gilead a patent for...
Read more about Patent on Hep C drug rejected in Ukraine: Price of sofosbuvir will significantly reduce